FDA To Provide Updates On Critical Path Opportunities List Projects
Executive Summary
FDA will highlight the agency's involvement in Critical Path projects in the coming months, Deputy Commissioner for Operations Janet Woodcock said March 16
You may also be interested in...
European Union And Industry Launch Massive Pharmaceutical R&D Program
The European Commission and European drug makers have agreed to spend €2 billion, almost $3 billion, to develop technologies that can speed the development and delivery of new drugs to patients
“Critical Path” Is On The Road Forward; FDA Reports Industry Activity Is High
The Critical Path Initiative is entering 2007 with growing momentum, bolstered by a new, tailored agency infrastructure and increased industry awareness of FDA's initiative to spur drug development
“Critical Path” Is On The Road Forward; FDA Reports Industry Activity Is High
The Critical Path Initiative is entering 2007 with growing momentum, bolstered by a new, tailored agency infrastructure and increased industry awareness of FDA's initiative to spur drug development